[1] 朱华亭, 李文凤. 自拟参芪升白汤预防非小细胞肺癌患者化疗所致白细胞减少症的临床疗效观察[J]. 中国社区医师(医学专业), 2012, 14(36): 196-197.
[2]Kim YS, Sun JM, Ahn JS, et al. The optimal duration of vitamin supplementation prior to the first dose of pemetrexed in patients with non-small-cell lung cancer[J]. Lung Cancer, 2013, 81(2): 231-235.
[3]沈自尹, 王文建. 中医虚证辨证参考标准[J].中西医结合杂志, 1996, 6(10): 598- 598.
[4]郑筱萸. 中药新药临床研究指导原则[M]. 北京: 中国医药科技出版社, 2002: 173-180, 223-230.
[5]Komaki R, Wei X, Allen PK, et al. Phase I study of celecoxib with concurrent irinotecan, Cisplatin, and radiation therapy for patients with unresectable locally advanced non-small cell lung cancer[J]. Front Oncol, 2011,1:52.
[6] 张景屹,杜红娣.肺癌化疗患者癌因性疲乏状况调查分析[J].中国医药导报,2012,9(15):24-26.
[7]Lau DH, Moon J, Davies AM, et al. Southwestern oncology group phase II trial(S0526)of pemetrexed in bronchioloalveolar carcinoma subtypes of advanced adenocarcinoma[J]. Clin Lung Cancer, 2013, 14(4): 351-355.
[8] Manegold C, Vansteenkiste J, Cardenal F, et al. Randomized phaseⅡstudy of three doses of the integrin inhibitor cilenitide versus docetaxel as second-line treatment for patients with advanced non-small-cell lung cancer[J]. Invest New Drugs, 2013, 31(1): 175-182.
[9]梁芳. 生脉注射液联合清开灵注射液治疗晚期非小细胞肺癌恶病质20例[J]. 环球中医药, 2010, 3(2): 138-139.
[10] 何敏,周浴,邝军,等.扶正抗癌方联合化疗治疗非小细胞肺癌疗效研究[J].环球中医药,2014,7(4):278-281.
[11]张锦林, 倪美鑫, 顾海娟, 等. 补康灵预防非小细胞肺癌化疗后白细胞减少症的疗效观察[J].中华中医药学刊, 2012, 30(6): 1315-1316.
[12]王烨珣. rhG-CSF防治晚期肺癌化疗后白细胞减少的疗效[J]. 实用药物与临床, 2010, 13(1): 71-72.
[13]顾雨芳, 张映城, 施俊, 等. 复方阿胶浆防治胃癌患者化疗后白细胞减少的临床观察[J]. 环球中医药, 2012, 5(8): 614- 616.
[14]陈光宇, 丁红, 刘永家, 等. 黄芪总苷注射液人体耐受性Ⅰ期临床试验[J]. 环球中医药, 2013, 6(7): 514- 518.
[15]陈宇, 胡轶娟, 丰奕波, 等. 三黄三仙汤抗疲劳作用的实验研究[J]. 中华中医药学刊, 2013, 31(10): 2233-2235.
[16]陶静, 范欣生, 张欢. 黄芪治疗放疗化疗后白细胞减少症的应用分析[J]. 中医药学报, 2010, 38(6): 68-70.